The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

Wholesaler Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme

January 21, 2026 

Atlantic Biologicals Corporation, a pharmaceutical wholesaler based in Miami, has entered into a two-year deferred prosecution agreement with the Justice Department in connection with a criminal information filed in the Southern District of Florida charging it with one count of conspiracy to unlawfully distribute and dispense, and possess with intent to distribute, controlled substances. As part of the deferred prosecution agreement, Atlantic Biologicals admitted that its business unit National Apothecary Solutions (NAS), through its employees and agents, sold opioid pills to certain Houston area pill mill pharmacies, knowing and intending that the pharmacies would dispense the pills outside the usual course of professional practice and without a legitimate medical purpose. NAS will commence cessation of operations in or about January 2026, after selling over 14 million doses of opioids and opioid potentiators to pill mill pharmacies in Houston, Texas.

Joshua Weinstein, the former president of NAS, Atlantic Biologicals’ business unit that sold pharmaceutical opioids, other controlled and non-controlled drugs, and medical goods to independent pharmacies; Derrick Chad Atkinson, a former independent sales representative contracted by NAS; and Jason Smith, the former owner of Proven Rx Sales LLC (Proven), a consulting company that worked with NAS, each previously pled guilty to one count of conspiracy to unlawfully distribute and dispense, and possess with intent to distribute, controlled substances. Joseph Pesserillo and Cassandra Rivera, former employes of Proven, previously pled guilty to one count of conspiracy to use a communications facility to further commission of a felony controlled substance offense.

 

[Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme. DOJ 13 Jan 2026.]